Cargando…
False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland
This cross-sectional study evaluates the prevalence of false or misleading information in online direct-to-consumer advertising for off-label and unapproved ketamine in Maryland.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630893/ https://www.ncbi.nlm.nih.gov/pubmed/37934500 http://dx.doi.org/10.1001/jamanetworkopen.2023.42210 |
_version_ | 1785146055926480896 |
---|---|
author | Crane, Matthew A. DiStefano, Michael J. Moore, Thomas J. |
author_facet | Crane, Matthew A. DiStefano, Michael J. Moore, Thomas J. |
author_sort | Crane, Matthew A. |
collection | PubMed |
description | This cross-sectional study evaluates the prevalence of false or misleading information in online direct-to-consumer advertising for off-label and unapproved ketamine in Maryland. |
format | Online Article Text |
id | pubmed-10630893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-106308932023-11-15 False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland Crane, Matthew A. DiStefano, Michael J. Moore, Thomas J. JAMA Netw Open Research Letter This cross-sectional study evaluates the prevalence of false or misleading information in online direct-to-consumer advertising for off-label and unapproved ketamine in Maryland. American Medical Association 2023-11-07 /pmc/articles/PMC10630893/ /pubmed/37934500 http://dx.doi.org/10.1001/jamanetworkopen.2023.42210 Text en Copyright 2023 Crane MA et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License. |
spellingShingle | Research Letter Crane, Matthew A. DiStefano, Michael J. Moore, Thomas J. False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland |
title | False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland |
title_full | False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland |
title_fullStr | False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland |
title_full_unstemmed | False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland |
title_short | False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland |
title_sort | false or misleading claims in online direct-to-consumer ketamine advertising in maryland |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630893/ https://www.ncbi.nlm.nih.gov/pubmed/37934500 http://dx.doi.org/10.1001/jamanetworkopen.2023.42210 |
work_keys_str_mv | AT cranematthewa falseormisleadingclaimsinonlinedirecttoconsumerketamineadvertisinginmaryland AT distefanomichaelj falseormisleadingclaimsinonlinedirecttoconsumerketamineadvertisinginmaryland AT moorethomasj falseormisleadingclaimsinonlinedirecttoconsumerketamineadvertisinginmaryland |